Slide 1: Capital Markets Day 2026
Capital Markets Day 2026 • Company information • New reporting structure • Segment information • Supply chain Information booklet 12 May 2026
Slide 2: Disclaimer
Disclaimer The following applies to this presentation, the oral presentation of the information in this presentation by Oriola Corporation (the “Company” or “Oriola”) or any person on behalf of the Company, and any question-and-answer session that follows the oral presentation (collectively, the “In
Slide 3: Company information
Company information • General facts • Strategy • Sustainability • Management Team and Board of Directors • Ownership structure
Slide 4: Health for life since 1907
Health for life since 1907 Together with our customers, we are committed to building a healthier tomorrow by securing the safe, reliable distribution and use of pharmaceuticals and health and wellbeing products in society. By combining operational excellence with deep knowledge of the Nordic market,
Slide 5: Strong position in the health and wellbeing markets in Finland and Sweden
Strong position in the health and wellbeing markets in Finland and Sweden KEY FIGURES 2025 OUR LOCATIONS Invoicing Net sales EUR 4.2 EUR 201.6 billion million ESPOO ENKÖPING HELSINKI Adjusted EBITDA EUR 35.1 million 904 employees STOCKHOLM MÖLNLYCKE COPENHAGEN CAPITAL MARKETS DAY 12 MAY 2026
Slide 6: The leading specialist in wholesale of pharmaceuticals and health products
The leading specialist in wholesale of pharmaceuticals and health products Strong partnerships Enhanced efficiency Portfolio and market expansion Putting our customers at the centre, using Investing in capacity, infrastructure and Expanding services, brands and segments data-driven insight and comme
Slide 7: Delivering customer value through integrated service offering
Delivering customer value through integrated service offering We manage end-to-end flows across markets, reducing complexity for our customers Customer Services Products experience The Services segment The Products segment consists of distribution of consists of wholesale of pharmaceuticals, value-a
Slide 8: Distribution services
Distribution services We manage a high-quality, GDP-compliant supply chain for safe and reliable deliveries of pharmaceuticals and health and wellbeing products in the Nordics. We combine automated processes, expert handling, and a strong local presence to meet the strict regulatory demands of pharm
Slide 9: Advisory services
Advisory services We help pharmaceutical companies succeed with tailored services across the entire product lifecycle – from market entry and regulatory compliance to commercial strategy and market insights. Our advisory services combine deep knowledge of Nordic healthcare systems and regulatory req
Slide 10: Wholesale services
Wholesale services Our wholesale business connects suppliers and resellers of health and wellbeing products. We offer a broad selection of traded goods and over-the-counter (OTC) products, special licensed medicines, and parallel imports, supported by reliable logistics and local market expertise. W
Slide 11: A sustainable future begins with health
A sustainable future begins with health As a distributor and wholesaler of pharmaceuticals and health and wellbeing products, we have a positive impact on society and people's lives. Our commitment to sustainability also includes minimising our environmental footprint and operating responsibly. Comm
Slide 12: Advancing a healthier society
Advancing a healthier society SOCIETY ENVIRONMENT • Ensure safe and accurate deliveries Near-term targets • Maintain the highest quality and • Reduce absolute Scope 1 and 2 GHG emissions 67% safety standards for health products by 2030 from a 2023 base year • 69% of Oriola’s suppliers by spend, cove
Slide 13: Sustainability achievements 2025
Sustainability achievements 2025 SOCIETY PEOPLE ENVIRONMENT GOVERNANCE Ensure safe and accurate Promoting a sustainable people Oriola commits to reach net-zero Ensure transparent and deliveries. journey. emissions across the value chain responsible operations and Picking accuracy 99.8% (target Safet
Slide 14: Oriola Management Team
Oriola Management Team Katarina Gabrielson Mats Danielsson Katja Lundell Maria Lundell Mikael Nurmi CEO CFO Executive Vice President, Chief People Officer Chief Digital Officer Advisory Services Satu Nylén Petter Sandström Tuomas Tiilikainen Stig Tornell Executive Vice President, General Counsel Chi
Slide 15: Katarina Gabrielson, CEO, and Mats Danielsson, CFO
Katarina Gabrielson Mats Danielsson M. Sc. M. Sc. Econ. CEO CFO Swedish citizen Finnish citizen Shareholding: 182,949 Shareholding: 0 Katarina Gabrielson was appointed as Oriola Mats Danielsson was appointed Oriola Corporation's Corporation’s CEO as of 10 May 2022. Chief Financial Officer and member
Slide 16: Katja Lundell and Maria Lundell
Katja Lundell Maria Lundell M. Sc. (Economics) MA Executive Vice President, Chief People Officer (CPO) Advisory Services Finnish citizen Finnish and British citizen Shareholding: 901 Shareholding: 0 Katja Lundell was appointed as Executive Vice President, Maria Lundell was appointed Chief People Off
Slide 17: Mikael Nurmi and Satu Nylén
Mikael Nurmi Satu Nylén M.Sc (Industrial Economics) M. Sc. (Economics) Chief Digital Officer Executive Vice President, Finnish citizen Services and Products Shareholding: 47,267 Finnish citizen Shareholding: 17,509 Mikael Nurmi was appointed Oriola Corporation’s Satu Nylén was appointed as Executive
Slide 18: Petter Sandström and Tuomas Tiilikainen
Petter Sandström Tuomas Tiilikainen LL.M M. Sc. (Engineering) General Counsel Chief Supply Chain Officer Finnish citizen Finnish citizen Shareholding: 68,823 Shareholding: 0 Petter Sandström was appointed Oriola’s Legal Tuomas Tiilikainen was appointed Oriola’s Chief Counsel in 2008, General Counsel
Slide 19: Stig Tornell
Stig Tornell Sc. (Business Administration and Economics) Executive Vice President, Sales Swedish citizen Shareholding: 0 Stig Tornell was appointed Oriola Corporation’s Executive Vice President, Sales and member of the Oriola Management Team as of 1 April 2025. Tornell has extensive experience in sa
Slide 20: Board of Directors
Board of Directors Heikki Westerlund Petra Axdorff Ann Carlsson Meyer Yrjö Närhinen Chairman of the Board Member of the Board Member of the Board Member of the Board Shareholding: 267,501* Shareholding: 41,057 Shareholding: 41,057 Shareholding: 54,604 Ellinor Persdotter Pekka Pajamo Harri Pärssinen
Slide 21: Ownership structure
Ownership structure Ownership distribution, % 10 largest shareholders % of shares 3.6 Mariatorp Oy 14.95 6.8 5.3 Wipunen Varainhallinta Oy 4.96 9.2 Varma Mutual Pension Insurance Company Oriola AGM (2 April 4.26 2025) 45.7 Ilmarinen Mutual Pension Insurance Company approved the shareholder's 3.32 Ma
Slide 22: New reporting structure
& Oriola New reporting structure
Slide 23: Financial reporting changes to better reflect Oriola's value creation and improve transparency
Financial reporting changes to better reflect Oriola’s value creation and improve transparency Oriola is a service company offering value-adding logistics and advisory 1 Revenue recognition policy services and a wide portfolio of health • Oriola’s management has made a judgement of customer contract
Slide 24: Key figures
Key figures EUR million 2025 2025 2024 2024 Restated Restated Invoicing 4,201.2 4,201.2 3,771.8 3,771.8 Net sales 201.6 1,906.2 200.0 1,679.7 Adjusted EBITDA 35.1 35.1 33.4 33.4 EBITDA 20.3 20.3 27.2 27.2 Adjusted EBITDA % 17.4 1.8 16.7 2.0 EBITDA % 10.1 1.1 13.6 1.6 Profit for the period -27.2 -27.
Slide 25: Balance sheet
Balance sheet EUR million 2025 2025 2024 2024 EUR million 2025 2025 2024 2024 Restated Restated Restated Restated Non-current assets total 289.3 289.3 314.0 314.0 Equity attributable to 100.8 100.8 133.4 133.4 the parent company Current assets stakeholders Inventories 5.5 188.5 5.3 176.3 Non-Current
Slide 26: New reporting segments
New reporting segments New reporting segments The change in segment reporting Services Products clarifies the reporting of service- The Services segment consists of The Products segment consists of and product-driven businesses distribution of pharmaceuticals, value- wholesale of traded goods and ov
Slide 27: Services segment
Services segment The Services segment consists of distribution of pharmaceuticals, value-adding services and parallel import in the Nordics. The segment also includes advisory services and commercial data solutions.
Slide 28: Specialised products drive pharmaceutical market
Specialised products drive pharmaceutical market Top 5 fastest growing disease areas (EUR billion) Pharmaceutical markets SWE & FI (EUR billion) Finland Sweden Oncology Oncology Eyes & vision +7% Central nervous system Diabetes Musculoskel. 7 CAGR Diabetes Vaccines 6.2 5.8 Sweden Cardiovascular 6 5.
Slide 29: Finland cold chain medicine market. Four cold-chain medicine innovation waves
Finland cold chain medicine market. Four cold-chain medicine innovation waves • Oriola is one of the leading players within cold chain and has a strong opportunity to develop it further. Oriola already distributes for the manufacturers behind every major biologics wave of the next 5 years. (**) • Lo
Slide 30: Expert on two regulated markets
Expert on two regulated markets Sweden Finland Channel distribution Single channel / DTP* distribution Single channel / DTP* distribution Regulated establishment and ownership, Pharmacy establishment Free establishment, permission required permission required Pharmacy chain operations Allowed Not al
Slide 31: Finnish pharmacy legislation reform – overview
Finnish pharmacy legislation reform – overview Finland is implementing a phased reform of its pharmacy legislation to modernise the pharmacy market while safeguarding medicine availability, patient safety and a nationwide pharmacy network. The reform originally addressed: Second legislative package
Slide 32: Advisory Services
Advisory Services Advisory Services serves entire pharmaceutical product life-cycle and consists of five major service categories including a range of services with similar business models and synergistic capabilities. Clinical trial services Business process Access, evidence Commercial data & Growt
Slide 33: Products segment
Products segment The Products segment consists of wholesale of traded goods and over-the- counter (OTC) products covering Oriola’s own brands and special licensed medicines in Finland and Sweden. The segments also include the dose dispensing business in Finland. Note: The Products segment includes t
Slide 34: Consumer health market insights – channel shift
Consumer health market insights – channel shift Share of Over-the-Counter (OTC) and traded goods' products by channel in Finland and Sweden Finland Sweden 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Grocery Retailers 26% 27% Grocery Retailers 21% 20% 20% 20% 20% 20% 28% 29% 28% 28% O
Slide 35: Resilience to market changes
Resilience to market changes Multichannel coverage, balanced mix of categories Product segment: net sales by channel Product segment: net sales by category Retail speciality Other Own & exclusive brands • Established customer Grocery network via Distribution services Vets SLM • Cost-efficiency via c
Slide 36: Extensive offering of health and wellbeing products
Extensive offering of health and wellbeing products • Wide assortment of well-known global brands, market specific hero brands, innovative novelties and price fighters for each channel • Oriola owned private label brands e.g. Dexal sports nutrition, Reformi food seasoning and Moomin vitamins for chi
Slide 37: Dose market (FI)
Dose market (FI) • The Finnish dose dispensing market currently includes approximately 122,000 patients, representing a 5% increase compared to 2024. Oriola holds a market share of approx. 30%. • In Finland, approximately 633,000 individuals are aged over 75 years, representing the core demographic
Slide 38: Supply chain
& Oriola Supply chain
Slide 39: Efficient and high-quality supply chain
Efficient and high-quality supply chain KEY FACTS SUPPLY CHAIN LOCATIONS Commitment to deliver pharmaceuticals within 24 hours of ordering # of logistics customers # of packs per year per day ~300 million ~2,500 ESPOO ENKÖPING HELSINKI Supply chain FTE 374 GDP compliant STOCKHOLM MÖLNLYCKE CAPITAL M
Slide 40: Supply network located close to major market volumes
Supply network located close to major market volumes Strong focus quality, safety and accuracy of pharmaceutical delivery – picking accuracy was 99.8% in 2025 SWEDEN FINLAND FTEs 202 FTEs 146 Mölnlycke 7% 26% Espoo • Central warehouse • Central warehouse and • Vaccine distribution distribution centr
Slide 41: Health for life
Health for life